secwatch.observer — SEC 8-K summary
======================================

Issuer:     JOINT Corp (JYNT)
CIK:        0001612630
Form:       8-K
Filed at:   2025-08-07T23:59:59+00:00
Accession:  0001612630-25-000021
Event type: earnings
Sentiment:  negative
Materiality: 0.80
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Joint Corp Q2 rev $13.3M +5%, narrows loss; cuts FY system-wide sales guidance to $530-550M
--------------------------------------------------------------------------------

- Q2 revenue $13.3M (+5% YoY); consolidated net income $93K vs loss $3.6M; net loss from continuing ops $990K vs loss $1.7M.
- Adjusted EBITDA from continuing ops improved to $88K from loss $380K; consolidated Adj EBITDA up 52% to $3.2M.
- Refranchised 37 clinics for $11.2M, acquired NW regional developer territory for $2.8M; franchised now 92% of 967 clinics.
- Cuts FY 2025 system-wide sales guidance to $530-550M (from $550-570M); comp sales now low-single digit vs mid-single digit; raises consolidated Adj EBITDA guidance.
- Announced restatement of 2024 10-K and Q1 2025 10-Q for non-cash impairment errors; no impact on Adj EBITDA.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1612630/000161263025000021/0001612630-25-000021-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1612630/000161263025000021/jynt-20250807.htm
  HTML page:      https://secwatch.observer/filing/0001612630-25-000021

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer